EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

CRISPR-Cas Systems: Mechanisms, Variants, and Biomedical Applications: A Comprehensive Review

Augustine Chinedu Ihim, Kelechi Caroline Obi, Patrick Chinedu Obi, Ini Edeh, Donatus F.N Ozuruoke, Tochukwu Anthony Ikwelle

Journal of Drug Delivery and Therapeutics · 15.04.2026 · 16 (4) · 159-164

DOI: 10.22270/jddt.v16i4.7692 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Drug Delivery and Therapeutics, online erschienen am 15.04.2026. Verfasst von Augustine Chinedu Ihim und 5 weiteren Autor:innen. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

This review aims to provide a comprehensive synthesis of the mechanisms, classification, emerging variants, and biomedical applications of CRISPR-Cas systems, while critically evaluating current limitations and future directions in genome editing. Data Sources: Peer-reviewed literature was sourced from PubMed, Google Scholar, and institutional databases. Sources included primary research articles, systematic reviews, clinical trial reports, and authoritative commentary up till 2025. Study Selection: Studies were selected based on relevance to CRISPR-Cas mechanism, classification, therapeutic application, and emerging technologies. Priority was given to high-impact journals in molecular biology, genetics, and clinical medicine. Summary: CRISPR-Cas systems, originally characterized as adaptive immune mechanisms in prokaryotes, have been repurposed as highly precise genome engineering platforms. The two major system classes, defined by multi-protein versus single-effector complexes, encompass diverse types with distinct nuclease activities and target specificities. Key variants, including base editors, prime editors, and diagnostic platforms such as SHERLOCK and DETECTR, have substantially expanded functional capabilities. Biomedical applications span therapeutic gene correction in monogenic disorders, cancer immunotherapy, antiviral strategies, functional genomics, and disease modelling. Persistent challenges include off-target effects, delivery limitations, immune responses, and ethical concerns surrounding germline editing.

Conclusion

CRISPR-Cas technology represents a paradigm shift in molecular biology. Continued refinement of editing fidelity, delivery systems, and ethical frameworks will be essential for its safe and equitable clinical translation. Keywords: CRISPR-Cas systems, genome editing, Cas9 nuclease, gene knockout, gene therapy, base editing, prime editing

Zitieren

APA

Ihim, A. C., Obi, K. C., Obi, P. C., Edeh, I., Ozuruoke, D. F., & Ikwelle, T. A. (2026). CRISPR-Cas Systems: Mechanisms, Variants, and Biomedical Applications: A Comprehensive Review. Journal of Drug Delivery and Therapeutics, 16(4), 159-164. https://doi.org/10.22270/jddt.v16i4.7692

Vancouver

Ihim AC, Obi KC, Obi PC, Edeh I, Ozuruoke DF, Ikwelle TA. CRISPR-Cas Systems: Mechanisms, Variants, and Biomedical Applications: A Comprehensive Review. Journal of Drug Delivery and Therapeutics. 2026;16(4):159-164. doi:10.22270/jddt.v16i4.7692

BibTeX
@article{Ihim2026,
  author = {Ihim, Augustine Chinedu and Obi, Kelechi Caroline and Obi, Patrick Chinedu and Edeh, Ini and Ozuruoke, Donatus F.N and Ikwelle, Tochukwu Anthony},
  title = {CRISPR-Cas Systems: Mechanisms, Variants, and Biomedical Applications: A Comprehensive Review},
  journal = {Journal of Drug Delivery and Therapeutics},
  year = {2026},
  volume = {16},
  number = {4},
  pages = {159--164},
  doi = {10.22270/jddt.v16i4.7692}
}
Kostenlos starten →